adsilico: Venture Capital Funding History

adsilico gives medical device companies population-level evidence of how their medical implants will perform across the full diversity of real patients, to inform costly stages of development. Its proprietary Virtual Chimera™ technology generates fully synthetic patient populations from anonymised clinical imaging, and adsilico runs physics-based simulations across them under clinical oversight, delivering decision-ready insight on device design, sizing and patient selection. The result is safer devices, fewer late-stage failures and less reliance on animal testing. adsilico spun out of the University of Leeds in 2024 and is backed by PXN Ventures, Northern Gritstone, Parkwalk and Innovate UK.